Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (181-190 of 584) with videos related to

Pageof 59
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|March 22, 2015
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignanciesTalha Badar, Jorge E Cortes, Farhad Ravandi, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2019
Tyrosine Kinase Inhibitor-associated FibrothoraxAndres M Adrianza, Carlos A Jimenez, Grecia L Aldana, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapyMarylou Cardenas-Turanzas, Farhad Ravandi-Kashani, Jorge E Cortes, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemiaC Cameron Yin, Lynne V Abruzzo, Xiaoyan Qiu, et al.
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Biomedical Materials (Bristol, England)|March 19, 2015
In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatiteL Grenho, J Barros, C Ferreira, et al.
Cancer|April 8, 1999
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remissionJ E Cortes, H M Kantarjian, S O'Brien, et al.
Cancer|May 13, 2004
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemiaKevin E Sanders, Chul S Ha, Jorge E Cortes-Franco, et al.
Cancer|February 22, 2002
Central nervous system relapse in adults with acute lymphoblastic leukemiaUsha R Surapaneni, Jorge E Cortes, Deborah Thomas, et al.
Veterinary Parasitology|May 3, 2015
Trichinella britovi in a red fox (Vulpes vulpes) from PortugalAna Patrícia Lopes, Maria João Vila-Viçosa, Teresa Coutinho, et al.
Pageof 59

Showing results (181-190 of 584) with videos related to

Sort By:
Pageof 59
Clinical Lymphoma, Myeloma & Leukemia|March 22, 2015
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignanciesTalha Badar, Jorge E Cortes, Farhad Ravandi, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2019
Tyrosine Kinase Inhibitor-associated FibrothoraxAndres M Adrianza, Carlos A Jimenez, Grecia L Aldana, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapyMarylou Cardenas-Turanzas, Farhad Ravandi-Kashani, Jorge E Cortes, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemiaC Cameron Yin, Lynne V Abruzzo, Xiaoyan Qiu, et al.
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Biomedical Materials (Bristol, England)|March 19, 2015
In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatiteL Grenho, J Barros, C Ferreira, et al.
Cancer|April 8, 1999
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remissionJ E Cortes, H M Kantarjian, S O'Brien, et al.
Cancer|May 13, 2004
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemiaKevin E Sanders, Chul S Ha, Jorge E Cortes-Franco, et al.
Cancer|February 22, 2002
Central nervous system relapse in adults with acute lymphoblastic leukemiaUsha R Surapaneni, Jorge E Cortes, Deborah Thomas, et al.
Veterinary Parasitology|May 3, 2015
Trichinella britovi in a red fox (Vulpes vulpes) from PortugalAna Patrícia Lopes, Maria João Vila-Viçosa, Teresa Coutinho, et al.
Pageof 59